DIMENHYDRINATE Drug Patent Profile
✉ Email this page to a colleague
When do Dimenhydrinate patents expire, and when can generic versions of Dimenhydrinate launch?
Dimenhydrinate is a drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, Watson Labs, Watson Labs Teva, Wyeth Ayerst, Alra, Heather, and Nexgen Pharma Inc. and is included in nine NDAs.
The generic ingredient in DIMENHYDRINATE is dimenhydrinate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dimenhydrinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dimenhydrinate
A generic version of DIMENHYDRINATE was approved as dimenhydrinate by FRESENIUS KABI USA on June 23rd, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIMENHYDRINATE?
- What are the global sales for DIMENHYDRINATE?
- What is Average Wholesale Price for DIMENHYDRINATE?
Summary for DIMENHYDRINATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 21 |
| Patent Applications: | 4,173 |
| Drug Prices: | Drug price information for DIMENHYDRINATE |
| DailyMed Link: | DIMENHYDRINATE at DailyMed |
Recent Clinical Trials for DIMENHYDRINATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The University of The West Indies | Early Phase 1 |
| IWK Health Centre | Phase 4 |
| Ciusss de L'Est de l'Île de Montréal | N/A |
Medical Subject Heading (MeSH) Categories for DIMENHYDRINATE
Anatomical Therapeutic Chemical (ATC) Classes for DIMENHYDRINATE
US Patents and Regulatory Information for DIMENHYDRINATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 084767-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Heather | DIMENHYDRINATE | dimenhydrinate | TABLET;ORAL | 080841-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs Teva | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 080615-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nexgen Pharma Inc | DIMENHYDRINATE | dimenhydrinate | TABLET;ORAL | 085985-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 040519-001 | Jun 23, 2004 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 083531-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | DIMENHYDRINATE | dimenhydrinate | LIQUID;ORAL | 080715-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
